ELLIPSIS: Robust quantification of splicing in scRNA-seq.

Abstract

Motivation: Alternative splicing is a tightly regulated biological process, that due to its cell type specific behaviour, calls for analysis at the single cell level. However, quantifying differential splicing in scRNA-seq is challenging due to low and uneven coverage. Hereto, we developed ELLIPSIS, a tool for robust quantification of splicing in scRNA-seq that leverages locally observed read coverage with conservation of flow and intra-cell type similarity properties. Additionally, it is also able to quantify splicing in novel splicing events, which is extremely important in cancer cells where lots of novel splicing events occur.

Results: Application of ELLIPSIS to simulated data, proves that our method is able to robustly estimate Percent Spliced In values in simulated data, and allows to reliably detect differential splicing between cell types. Using ELLIPSIS on glioblastoma scRNA-seq data, we identified genes that are differentially spliced between cancer cells in the tumor core and infiltrating cancer cells found in peripheral tissue. These genes showed to play a role in a.o. cell migration and motility, cell projection organization and neuron projection guidance.

Availability and implementation: ELLIPSIS quantification tool: https://github.com/MarchalLab/ELLIPSIS.git.

Supplementary information: Supplementary data are available at Bioinformatics online.